Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5131-5140 of 11906

Edit search filters
  1. Management of Spastic Elbow Deformities

    Rochester, MN

  2. Onyx™ Liquid Embolic IDE Clinical Study

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate Autologous Adipose Derived Mesenchymal Stem Cells to Treat Spinal Cord Injury Patients

    Rochester, MN

  4. A Study To Evaluate The Effectiveness And Safety Of Pembrolizumab Combined With Bacillus Calmette-Guerin In High-Risk Non-Muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. (Apex) Bezuclastinib In Patients With Advanced Systemic Mastocytosis

    Scottsdale/Phoenix, AZ

  6. A Study To Evaluate DS-8201a Combined With Olaparib In HER2-Expressing Cancers With Expansion In Endometrial Cancer Patients Testing The Combination Of DS-8201a And Olaparib In HER2-Expressing Cancers With Expansion In Patients With Endometrial Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Genetically Engineered Cells (MUC1-Activated T-Cells) For The Treatment Of MUC1 Positive Recurrent Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ

  8. PRE-I-SPY Phase I/Ib Oncology Platform Program

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer. (PROTA)

    Rochester, MN

  10. A Study of the Role of Elevated Free Fatty Acids in Blood Plasma for the Regulation of Muscle Protein Manufacture

.

Mayo Clinic Footer